Eurofins Scientific Stock Forecast, Price & News

-4.07 (-3.36 %)
(As of 07/28/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume2,549 shs
Average Volume1,788 shs
Market Capitalization$20.83 billion
P/E Ratio29.63
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ERFSF News and Ratings via Email

Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter.

Eurofins Scientific logo

About Eurofins Scientific

Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World. The company was founded by Gilles G. Martin in 1987 and is headquartered in Luxembourg.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.79 out of 5 stars

Medical Sector

1530th out of 2,210 stocks

Private Households Industry

261st out of 383 stocks

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Eurofins Scientific (OTCMKTS:ERFSF) Frequently Asked Questions

Is Eurofins Scientific a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Eurofins Scientific in the last twelve months. There are currently 3 sell ratings, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Eurofins Scientific stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ERFSF, but not buy additional shares or sell existing shares.
View analyst ratings for Eurofins Scientific
or view top-rated stocks.

What stocks does MarketBeat like better than Eurofins Scientific?

Wall Street analysts have given Eurofins Scientific a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Eurofins Scientific wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Eurofins Scientific?

Eurofins Scientific saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 154,900 shares, an increase of 140.5% from the May 31st total of 64,400 shares. Based on an average trading volume of 1,600 shares, the days-to-cover ratio is presently 96.8 days.
View Eurofins Scientific's Short Interest

How has Eurofins Scientific's stock been impacted by Coronavirus (COVID-19)?

Eurofins Scientific's stock was trading at $495.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ERFSF shares have decreased by 76.4% and is now trading at $117.05.
View which stocks have been most impacted by COVID-19

Who are Eurofins Scientific's key executives?

Eurofins Scientific's management team includes the following people:
  • Gilles G. Martin, Chairman & Chief Executive Officer
  • Christian Wurst, Chief Operating Officer-Food & Environment Testing
  • Laurent Lebras, Director-Group Finance & Administration
  • François Vigneau, Managing Director-Food Division Southern Europe

Who are some of Eurofins Scientific's key competitors?

What is Eurofins Scientific's stock symbol?

Eurofins Scientific trades on the OTCMKTS under the ticker symbol "ERFSF."

How do I buy shares of Eurofins Scientific?

Shares of ERFSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eurofins Scientific's stock price today?

One share of ERFSF stock can currently be purchased for approximately $117.05.

How much money does Eurofins Scientific make?

Eurofins Scientific has a market capitalization of $20.83 billion and generates $6.21 billion in revenue each year. The company earns $616.27 million in net income (profit) each year or $3.95 on an earnings per share basis.

How many employees does Eurofins Scientific have?

Eurofins Scientific employs 51,516 workers across the globe.

What is Eurofins Scientific's official website?

The official website for Eurofins Scientific is www.eurofins.com.

Where are Eurofins Scientific's headquarters?

Eurofins Scientific is headquartered at 23 Val Fleuri, Luxembourg N4, 1526.

How can I contact Eurofins Scientific?

Eurofins Scientific's mailing address is 23 Val Fleuri, Luxembourg N4, 1526. The company can be reached via phone at (522) 618-5320 or via email at [email protected]

This page was last updated on 7/29/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.